CRISPR

CRISPR1-sfxn1

ID

ZDB-CRISPR-211206-1

Name

CRISPR1-sfxn1

Previous Names

None

Target

sfxn1 (1)

Sequence

5' - GGTCATCATGCATCCAGTGA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

The PAM site was "TGG".

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
hzu201	sfxn1

Expression

Gene expression in Wild Types + CRISPR1-sfxn1

No data available

Phenotype

Phenotype resulting from CRISPR1-sfxn1

No data available

Phenotype of all Fish created by or utilizing CRISPR1-sfxn1

Phenotype	Fish	Conditions	Figures
whole organism hbbe2 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte hbbe1.1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
whole organism hbbe1.1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
whole organism alas2 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 4 from Bao et al., 2021
nucleate erythrocyte hemoglobin amount, ameliorated	sfxn1^{hzu201/hzu201} (AB)	chemical treatment by environment: pyridoxine	Fig. 5 from Bao et al., 2021
nucleate erythrocyte alas2 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 4 from Bao et al., 2021
nucleate erythrocyte hbbe2 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
head sfxn1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 1 from Bao et al., 2021
nucleate erythrocyte hbbe3 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
eye sfxn1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 1 from Bao et al., 2021
nucleate erythrocyte hbae1.1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte hemoglobin decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 2, Fig. 4, Fig. 5 from Bao et al., 2021
whole organism sfxn1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 1 from Bao et al., 2021
whole organism hbbe3 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte hemoglobin amount, ameliorated	sfxn1^{hzu201/hzu201} (AB)	chemical treatment by environment: 5-aminolevulinate	Fig. 5 from Bao et al., 2021
whole organism hbae3 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte nucleus ratio nucleate erythrocyte cytoplasm, ameliorated	sfxn1^{hzu201/hzu201} (AB)	chemical treatment by environment: 5-aminolevulinate	Fig. 5 from Bao et al., 2021
nucleate erythrocyte hbae3 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
whole organism hbae1.1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
blood sfxn1 expression decreased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 1 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased amount, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte gata1a expression increased distribution, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 3 from Bao et al., 2021
nucleate erythrocyte alas2 expression increased distribution, abnormal	sfxn1^{hzu201/hzu201} (AB)	standard conditions	Fig. 4 from Bao et al., 2021
nucleate erythrocyte nucleus increased ratio nucleate erythrocyte cytoplasm, abnormal	sfxn1^{hzu201/hzu201} (AB)	control	Fig. 3, Fig. 5 from Bao et al., 2021

Citations